Trevi Therapeutics Aktie
10,19
USD
+0,04
USD
+0,39
%
10,19
USD
+0,05
USD
+0,49
%
Werbung
Trevi Therapeutics Aktie Analyse
| 03.06.19 | Trevi Therapeutics Outperform | BMO Capital Markets | |
| 03.06.19 | Trevi Therapeutics Buy | Needham & Company, LLC |
Werbung
Werbung